Tag:
Novelos
Latest Headlines
Latest Headlines
Troubled Novelos touts promising breast cancer data
After suffering a serious setback when NOV-002 flunked a late-stage clinical trial for lung cancer earlier this year, Novelos says the same drug proved effective in combination with chemotherapy
Novelos shelves failed lung cancer program
Novelos Therapeutics is opting to dump a lead program for non-small cell lung cancer. The Newton, MA-based developer confirmed that NOV-002 had failed both primary and secondary endpoints for NSCLC
Novelos shares hammered after Ph3 fiasco
Novelos (NVLT) announced this morning that its pivotal Phase III trial for its lead product--NOV-002--failed to hit the primary endpoint. Investors bailed quickly on the news, with the developer's
